605
Views
44
CrossRef citations to date
0
Altmetric
Original Articles

Hepatoprotective Effects of Whey Protein on D-Galactosamine-Induced Hepatitis and Liver Fibrosis in Rats

, &
Pages 1281-1285 | Received 31 Jan 2006, Accepted 07 Mar 2006, Published online: 22 May 2014

  • 1) Marshall, K., Therapeutic applications of whey protein. Altern. Med. Rev., 9, 136–156 (2004).
  • 2) Hara, K., Ikeda, M., Saito, S., Matsumoto, S., Numata, K., Kato, N., Tanaka, K., and Sekihara, H., Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Hepatol. Res., 24, 228 (2002).
  • 3) Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K., and Kato, N., Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun., 245, 549–553 (1998).
  • 4) Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., and Sekihara, H., Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: a pilot study. Jpn. J. Cancer Res., 90, 367–371 (1999).
  • 5) Yamaguchi, M., Matsuura, M., Kobayashi, K., Sasaki, H., Yajima, T., and Kuwata, T., Lactoferrin protects against development of hepatitis caused by sensitization of Kupffer cells by lipopolysaccharide. Clin. Diagn. Lab. Immunol., 8, 1234–1239 (2001).
  • 6) Haversen, L., Ohlsson, B. G., Hahn-Zoric, M., Hanson, L. A., and Mattsby-Baltzer, I., Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B. Cell Immunol., 220, 83–95 (2002).
  • 7) Mattsby-Baltzer, I., Roseanu, A., Motas, C., Elverfors, J., Engberg, I., and Hanson, L. A., Lactoferrin or a fragment there of inhibits the endotoxin-induced interleukin-6 response in human monocytic cells. Pediatr. Res., 40, 257–262 (1996).
  • 8) Watanabe, A., Okada, K., Shimizu, Y., Wakabayashi, H., Higuchi, K., Niiya, K., Kuwabara, Y., Yasuyama, T., Ito, H., Tsukishiro, T., Kondoh, Y., Emi, N., and Kohri, H., Nutritional therapy of chronic hepatitis by whey protein (non-heated). J. Med., 31, 283–302 (2000).
  • 9) Keppler, D., Lesch, R., Reutter, W., and Decker, K., Experimental hepatitis induced by D-galactosamine. Exp. Mol. Pathol., 9, 279–290 (1968).
  • 10) Jonker, A. M., Dijkhuis, F. W., Kroese, F. G., Hardonk, M. J., and Grond, J., Immunopathology of acute galactosamine hepatitis in rats. Hepatology, 11, 622–627 (1990).
  • 11) Jonker, A. M., Dijkhuis, F. W., Boes, A., Hardonk, M. J., and Grond, J., Immunohistochemical study of extracellular matrix in acute galactosamine hepatitis in rats. Hepatology, 15, 423–431 (1992).
  • 12) Decker, K., and Keppler, D., Galactosamine hepatitis: key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death. Rev. Physiol. Biochem. Pharmacol., 71, 77–106 (1974).
  • 13) Decker, K., Mechanisms and mediators in hepatic necrosis. Gastroenterol. Jpn., 28, 20–25, discussion 33–35 (1993).
  • 14) Funatsu, K., Ishii, H., Shigeta, Y., Morita, A., and Tsuchiya, M., D-galactosamine induced hepatic cirrhosis: its ultrastructural and biochemical studies in rat. Acta Hepatogastroenterol (Stuttgart), 25, 97–104 (1978).
  • 15) Jonker, A. M., Dijkhuis, F. W., Hardonk, M. J., Moerkerk, P., Ten Kate, J., and Grond, J., Immunohistochemical study of hepatic fibrosis induced in rats by multiple galactosamine injections. Hepatology, 19, 775–781 (1994).
  • 16) Lesch, R., Keppler, D., Reutter, W., Rudigier, J., Oehlert, W., and Decker, K., Development of experimental liver cirrhosis by D-galactosamine: histological, biochemical and autoradiographic studies in rats. Virchows Arch. B Cell Pathol., 6, 57–71 (1970).
  • 17) Eng, F. J., Friedman, S. L., and Fibrogenesis, I., New insights into hepatic stellate cell activation: the simple becomes complex. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G7–G11 (2000).
  • 18) Pinzani, M., and Rombouts, K., Liver fibrosis: from the bench to clinical targets. Dig. Liver Dis., 36, 231–242 (2004).
  • 19) Schaefer, B., Rivas-Estilla, A. M., Meraz-Cruz, N., Reyes-Romero, M. A., Hernandez-Nazara, Z. H., Dominguez-Rosales, J. A., Schuppan, D., Greenwel, P., and Rojkind, M., Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am. J. Pathol., 162, 1771–1780 (2003).
  • 20) Sudo, K., Yamada, Y., Moriwaki, H., Saito, K., and Seishima, M., Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine, 29, 236–244 (2005).
  • 21) Tracey, K. J., Beutler, B., Lowry, S. F., Merryweather, J., Wolpe, S., Milsark, I. W., Hariri, R. J., Fahey, T. J., 3rd, Zentella, A., Albert, J. D., Shires, G. T., and Cerami, A., Shock and tissue injury induced by recombinant human cachectin. Science, 234, 470–474 (1986).
  • 22) Wakabayashi, G., Gelfand, J. A., Jung, W. K., Connolly, R. J., Burke, J. F., and Dinarello, C. A., Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia: Comparison to Escherichia coli. J. Clin. Invest., 87, 1925–1935 (1991).
  • 23) Shito, M., Balis, U. J., Tompkins, R. G., Yarmush, M. L., and Toner, M., A fulminant hepatic failure model in the rat: involvement of interleukin-1 beta and tumor necrosis factor-alpha. Dig. Dis. Sci., 46, 1700–1708 (2001).
  • 24) Lozano, J. M., Padillo, J., Montero, J. L., Pena, J., De la Mata, M., and Muntane, J., Immunomodulatory activity of TNF-alpha during acute liver injury induced by D-galactosamine and its protection by PGE1 in rats. Int. Immunopharmacol., 3, 197–207 (2003).
  • 25) Galanos, C., Freudenburg, M. A., and Reutter, W., Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA, 76, 5939–5943 (1979).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.